Stock Fundamentals

Company Information

Company Name
BIOLIDICS LIMITED
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
SG
Currency: SGD
Full Time Employees: 16
Phone: 65 6482 0668
Fiscal Year End: December
Description:

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also engages in technology development, technology transfer, marketing, sale and distribution of biomedical technology, life and medicine science related products and services, integrated marketing services provider in the gaming industry, multi-channel networking and live-streaming and investment activities. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. Embracing Future Holdings Limited was incorporated in 2009 and is based in Singapore.

Address:

122 Emerald Hill, Singapore, Singapore, 229405

Directors & Officers

Name Title Year Born
Mr. Hua Zhu Executive Chairman 1977
Mr. Lu Chen President & Executive Director NA
Prof. Chwee Teck Lim Founder and Advisor NA
Mr. Tan Swee Jin Co-Founder and Technical Advisor NA
Mr. Lau Wei Kian Financial Controller 1983
Ms. Hafiza Alwi Nor FCIS Company Secretary NA

Shares Statistics

Shares Outstanding: 1.73B
Shares Float: 813.97M
% Insiders: 5,369.00%
% Institutions: 30.10%

Valuation Metrics

Enterprise Value: $90.26M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $84.94M
EBITDA: $-3.73M
Book Value: $0.00
Earnings/Share: $0.00
Profit Margin: -75.31%
Operating Margin: -94.35%
ROA (TTM): -50.21%
ROE (TTM): -244.45%
Revenue (TTM): $5.26M
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 145.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.17x 1.40x 0.70x -39.44x -0.68x
2024-12-31 0.35x 0.38x 0.63x -43.64x -0.39x
2023-12-31 0.22x -0.31x 3.92x -8.97x -0.62x
2022-12-31 0.99x -1.00x 1.28x -17.58x -0.20x
2021-12-31 2.53x 1.18x 0.80x -15.90x -0.60x
2020-12-31 5.65x 0.45x 0.56x -36.06x -1.06x
2019-12-31 5.44x 0.00x 0.19x -708.63x 0.00x
2018-12-31 8.65x 0.00x 0.12x -9.34x 0.00x
2017-12-31 0.37x -0.27x 5.58x N/A -1.14x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 8YY.SG!